ODDO BHF Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

ODDO BHF Asset Management’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.33M	Sell	11,074 -21,939	-66%	-$6.62M	0.15%	122
2026 Q1	$10.9M	Buy	33,013 +2,880	+10%	+$980K	0.43%	58
2025 Q4	$12M	Sell	30,133 -7,794	-21%	-$3.45M	0.45%	56
2025 Q3	$17.3M	Buy	37,927 +1,987	+6%	+$809K	0.66%	46
2025 Q2	$11.7M	Buy	35,940 +16,119	+81%	+$4.46M	0.45%	65
2025 Q1	$5.35M	Buy	+19,821	New	+$5.09M	0.22%	126

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ODDO BHF Asset Management's ALNY Position: Q2 2026 in Review

ODDO BHF Asset Management reduced its Alnylam Pharmaceuticals (ALNY) stake by 66% in Q2 2026, selling an estimated $6.62M and leaving 11,074 shares worth $3.33M. The position accounts for 0.15% of the portfolio, ranked #122.

ODDO BHF Asset Management first reported a position in ALNY in Q1 2025 and has held it in 6 quarters since. The position peaked at $17.3M in Q3 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

ODDO BHF Asset Management held 11,074 shares of Alnylam Pharmaceuticals worth $3.33M as of Q2 2026.
ODDO BHF Asset Management sold 21,939 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $6.62M.
Alnylam Pharmaceuticals made up 0.15% of ODDO BHF Asset Management's portfolio in Q2 2026, its #122 holding.
ODDO BHF Asset Management first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
ODDO BHF Asset Management's Alnylam Pharmaceuticals position peaked at $17.3M in Q3 2025.
788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on ODDO BHF Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.